Department of Research, Cancer Registry of Norway, Oslo, Norway
Institute of Oncology "Prof. Dr. Ion Chiricuţă" Cluj-Napoca (IOCN), Cluj-Napoca, Romania.
BMJ Open. 2022 Feb 23;12(2):e053954. doi: 10.1136/bmjopen-2021-053954.
In 2020 in Europe, Romania had the second highest incidence and mortality rates of cervical cancer, after Montenegro. To address cervical cancer in the country, the Romanian government established a national cervical cancer screening programme in 2012. The programme provides free testing as well as free treatment in the event of cervical precancer diagnosis for women 25-64 years old with health insurance who are referred from a programme-registered general practitioner. Participation in screening, retesting and follow-up for detected precancerous lesions is suboptimal, thus reducing the overall effectiveness of the programme.
The overall aim of the study is to examine facilitators and barriers to cervical cancer screening follow-up after an abnormal cervical cancer screening examination among underserved women living in remote areas of Romania. We have the following specific research questions: (1) what are the knowledge, perspectives and experiences of women living in remote areas of Romania with cervical cancer screening and (2) what are the knowledge, perspectives and experiences of women living in remote areas of Romania with follow-up information and services after abnormal cervical cancer screening results.
We will conduct an exploratory qualitative study using semi-structured interviews. Data analysis will be based on the thematic analysis outlined by Braun and Clarke. We will use QSR International's NVivo V.12 as the qualitative data analysis software for both data management and analysis.
Study findings will inform recommendations for the Romania national policy for the cervical cancer screening programme, with a particular focus on underserved women living in remote areas with limited access to healthcare services. They will also be disseminated to relevant conferences and meetings. Ethics approval was obtained from Romania (Ref. 199/1501.2021 application no. 661/15.01.2021) and Norway (Ref. 12929853).
2020 年,在欧洲,罗马尼亚的宫颈癌发病率和死亡率仅次于黑山,位居第二。为了解决该国的宫颈癌问题,罗马尼亚政府于 2012 年建立了国家宫颈癌筛查计划。该计划为有医疗保险的 25-64 岁女性提供免费检测以及免费治疗,前提是这些女性由项目注册的全科医生转诊而来,并被诊断为宫颈癌前病变。然而,参与筛查、复查和随访宫颈癌前病变的人数并不理想,这降低了该计划的整体效果。
本研究的总体目的是研究罗马尼亚偏远地区服务不足的妇女在接受异常宫颈癌筛查检查后进行宫颈癌筛查随访的促进因素和障碍。我们有以下具体研究问题:(1)罗马尼亚偏远地区的妇女对宫颈癌筛查的知识、观点和经验如何;(2)罗马尼亚偏远地区的妇女对异常宫颈癌筛查结果后的随访信息和服务的知识、观点和经验如何。
我们将使用半结构式访谈进行探索性定性研究。数据分析将基于 Braun 和 Clarke 概述的主题分析。我们将使用 QSR International 的 NVivo V.12 作为定性数据分析软件,用于数据管理和分析。
研究结果将为罗马尼亚国家宫颈癌筛查计划政策提供建议,特别是关注服务不足的、生活在偏远地区且难以获得医疗服务的妇女。研究结果还将在相关会议和会议上进行传播。该研究已获得罗马尼亚(Ref. 199/1501.2021 申请号 661/15.01.2021)和挪威(Ref. 12929853)的伦理批准。